While stage II FBXW7 wild-type patients showed a trend toward better survival, no significant OS difference was observed overall between mutant (7.5%) and wild-type (92.5%) tumors in stage I–III CRC.
← all excerpts
FBXW7 Gene Mutation and Expression in Colorectal Cancer (CRC): A Systematic Review from Molecular Mechanisms to Clinical Translation.
1
—
—